Michael CPA - Biogen Ex CFO
BIIB Stock | MXN 3,777 56.70 1.52% |
Insider
Michael CPA is Ex CFO of Biogen Inc
Age | 59 |
Phone | 617 679 2000 |
Web | https://www.biogen.com |
Biogen Management Efficiency
The company has return on total asset (ROA) of 0.076 % which means that it generated a profit of $0.076 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2023 %, meaning that it generated $0.2023 on every $100 dollars invested by stockholders. Biogen's management efficiency ratios could be used to measure how well Biogen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 14 records | INSIDER Age | ||
Jacquie CFA | Gilead Sciences | N/A | |
Diane Wilfong | Gilead Sciences | 61 | |
Jitendra Tyagi | Bristol Myers Squibb | N/A | |
Michael Quigley | Gilead Sciences | N/A | |
Cari Gallman | Bristol Myers Squibb | N/A | |
Giovanni MD | Bristol Myers Squibb | 58 | |
Timothy Power | Bristol Myers Squibb | N/A | |
Sandra Esq | Bristol Myers Squibb | 62 | |
Linda Higgins | Gilead Sciences | 61 | |
Deborah Telman | Gilead Sciences | 58 | |
David Elkins | Bristol Myers Squibb | 55 | |
Greg Meyers | Bristol Myers Squibb | 50 | |
BCH BM | Bristol Myers Squibb | 57 | |
Jyoti Mehra | Gilead Sciences | 47 |
Management Performance
Return On Equity | 0.2 | |||
Return On Asset | 0.076 |
Biogen Inc Leadership Team
Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Viehbacher, CEO Pres | ||
Robin Kramer, Chief Accounting Officer, Vice President | ||
Sanjay Jariwala, Senior Vice President - Worldwide Medical | ||
Ginger Gregory, Chief Human Resource Officer, Executive Vice President | ||
Anabella Villalobos, Senior Vice President - Biotherapeutic & Medicinal Sciences (BTMS) | ||
Susan Esq, Chief VP | ||
Michael CPA, Ex CFO | ||
Natacha Gassenbach, Chief Affairs | ||
Nicole Murphy, Head Technology | ||
Michael Hencke, Head Relations |
Biogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.2 | |||
Return On Asset | 0.076 | |||
Profit Margin | 0.28 % | |||
Operating Margin | 0.29 % | |||
Current Valuation | 861.61 B | |||
Shares Outstanding | 144 M | |||
Shares Owned By Insiders | 0.68 % | |||
Shares Owned By Institutions | 89.99 % | |||
Price To Earning | 169.05 X | |||
Price To Book | 3.30 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |